Showing results (61-70 of 186) with videos related to
Sort By:
Pageof 19
Antimicrobial Agents and Chemotherapy|May 17, 2017
Efficacy and Pharmacokinetics of the Combination of OP0595 and Cefepime in a Mouse Model of Pneumonia Caused by Extended-Spectrum-Beta-Lactamase-Producing Klebsiella pneumoniaeNorihito Kaku, Kosuke Kosai, Kazuaki Takeda, et al.Antimicrobial Agents and Chemotherapy|June 26, 2019
Efficacy of Azithromycin in a Mouse Pneumonia Model against Hospital-Acquired Methicillin-Resistant Staphylococcus aureusYu Yamashita, Kentaro Nagaoka, Hiroki Kimura, et al.Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|March 30, 2021
Prolonged viral clearance of severe acute respiratory syndrome coronavirus 2 in the older aged populationAkitoshi Ueno, Hitoshi Kawasuji, Yuki Miyajima, et al.Scientific Reports|July 1, 2022
A novel hamster model of SARS-CoV-2 respiratory infection using a pseudotyped virusHiroshi Yamada, So-Ichiro Sasaki, Hideki Tani, et al.Geriatrics & Gerontology International|September 11, 2023
The clinical characteristics and molecular epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) among very elderly people in JapanFujiko Mitsumoto-Kaseida, Yoshitomo Morinaga, Daisuke Sasaki, et al.International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|April 29, 2026
Clindamycin demonstrates clinical effectiveness for bacteremic M1UKStreptococcus pyogenes pneumonia: A case report and in vitro evidence of notable antitoxin effects on M1UKMasayoshi Ezaki, Tien Manh Nguyen, Hitoshi Kawasuji, et al.Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|December 1, 2015
Antimicrobial susceptibility and molecular characteristics of methicillin-resistant Staphylococcus aureus in a Japanese secondary care facilityYumiko Kimura, Yoshitomo Morinaga, Norihiko Akamatsu, et al.The Open Microbiology Journal|July 12, 2017
Risk Factors for Acquisition of Fluoroquinolone or Aminoglycoside Resistance in Addition to Carbapenem Resistance in Pseudomonas AeruginosaKosuke Kosai, Norihito Kaku, Naoki Uno, et al.Experimental Lung Research|October 14, 2010
In vivo efficacy of sivelestat in combination with pazufloxacin against Legionella pneumoniaYoshitomo Morinaga, Katsunori Yanagihara, Nobuko Araki, et al.Pulmonary Pharmacology & Therapeutics|August 26, 2011
In vivo efficacy of KRP-109, a novel elastase inhibitor, in a murine model of severe pneumococcal pneumoniaKoichi Yamada, Katsunori Yanagihara, Nobuko Araki, et al.Pageof 19